Q2 2023 Holdings
Filed 2023-08-14 | 40 holdings | $510.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $34.6M | 3,363,688 | 6.8% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $31.2M | 677,426 | 6.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $29.4M | 589,211 | 5.8% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $28.1M | 1,550,184 | 5.5% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $27.4M | 1,465,151 | 5.4% |
| Point Biopharma Global Inc | COM | 730541109 | $27.2M | 3,000,000 | 5.3% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $27.0M | 3,295,000 | 5.3% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $20.9M | 968,795 | 4.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $20.4M | 530,000 | 4.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $20.1M | 1,941,581 | 3.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $19.6M | 600,000 | 3.8% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $18.2M | 894,333 | 3.6% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $17.8M | 297,082 | 3.5% |
| Evolus Inc(EOLS) | COM | 30052C107 | $17.7M | 2,434,048 | 3.5% |
| Aerovate Therapeutics Inc | COM | 008064107 | $16.0M | 932,158 | 3.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $14.2M | 123,600 | 2.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $12.9M | 411,453 | 2.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $12.7M | 772,000 | 2.5% |
| Optinose Inc | COM | 68404V100 | $10.9M | 8,839,939 | 2.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $9.7M | 598,550 | 1.9% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $9.3M | 546,059 | 1.8% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $8.8M | 701,392 | 1.7% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $8.6M | 2,268,057 | 1.7% |
| Apellis Pharmaceuticals Inc(APLS)Put | COM | 03753U106 | $8.6M | 94,700 | 1.7% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $7.1M | 1,083,317 | 1.4% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $6.7M | 601,322 | 1.3% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $6.3M | 350,000 | 1.2% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $5.6M | 1,022,537 | 1.1% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $5.5M | 4,737,368 | 1.1% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $5.1M | 1,051,267 | 1.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $4.6M | 500,000 | 0.9% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $4.5M | 938,067 | 0.9% |
| Precision Biosciences Inc | COM | 74019P108 | $3.9M | 7,469,736 | 0.8% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $3.1M | 584,458 | 0.6% |
| Aclaris Therapeutics Inc(ACRS)Put | COM | 00461U105 | $2.6M | 255,000 | 0.5% |
| Talaris Therapeutics Inc | COM | 87410C104 | $2.0M | 666,033 | 0.4% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $1.2M | 37,500 | 0.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $921.6K | 60,000 | 0.2% |
| Mersana Therapeutics IncCall | COM | 59045L106 | $230.3K | 70,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE)Put | COM | 98420N105 | $104.0K | 2,700 | 0.0% |